Cannabis-Based Medical Products Aid Primary Insomnia
Findings seen in as little as one month of treatment through 18 months of treatment
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing
59.0 Percent of Overdose Deaths Involved Stimulants in 2021 to 2024
People who died of overdoses involving stimulants and no opioids were older, more often had history of CVD
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift
Jim O’Neill Steps in as Acting CDC Chief Amid Firing, Resignations
Healthy Eating, Physical Activity Reduce Risk for Alcohol-Related Liver Mortality
Findings seen across patterns of alcohol consumption, including nonheavy, heavy, and binge drinking
Child’s ZIP Code Tied to Odds of Being Injured, Killed by a Firearm
Incidence of pediatric firearm-related injury hospital encounters increases as neighborhood opportunity decreases
GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis
GLP-1 RAs linked to lower risk among those with type 2 diabetes and without diabetes; greater protection seen versus metformin, insulin
Women Have Worse Outcomes Than Men With Beta-Blockers After Acute MI
Incidence of primary end point of death, MI, heart failure hospitalization up with beta-blockers in women, but not in men
Use of AI Can Help Identify Coronary Thin-Cap Fibroatheromas
Significant association seen for AI-TCFA with primary outcome of composite of any-cause death, nonfatal MI, unplanned revascularization at two years
